UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Evaluation of new iron chelators for clinical use

Porter, JB; (1996) Evaluation of new iron chelators for clinical use. ACTA HAEMATOL-BASEL , 95 (1) 13 - 25.

Full text not available from this repository.

Abstract

Evaluation of new chelators for clinical use is limited by the availability of models which will predict the therapeutic safety margin of chelators in iron-overloaded humans such as those with thalassaemia major. Animal models show significant differences with respect to the relative toxicity of different chelators compared with humans. These differences can be ascribed to several factors: differences in iron metabolism between different species, human metabolims being significantly more conservative than in rodents or nonhuman primates; differences in drug metabolism between different species which are often difficult to predict from first principles, and difficulties in obtaining iron-overloaded models that are truly representative of transfusional iron overload clinically. These differences have been highlighted by clinical studies on hydroxypyridinone iron chelators such as 1,2-dimethyl-3-hydroxypyridin-4-one (L1, CP20, deferiprone) and 1,2-diethyl-3-hydroxypyridin-4-one (CP94). New tissue culture approaches towards understanding the mechanisms of neutropenia, cytostasis and apoptosis induced by chelators as well as the relative rates of inhibition of non-haem-iron-containing enzymes such as ribonucleotide reductase are predicted to identify chelators with a higher therapeutic safety margin.

Type: Article
Title: Evaluation of new iron chelators for clinical use
Keywords: iron chelators, iron overload, apoptosis, ribonucleotide reductase, hydroxypyridinone, 3-HYDROXYPYRIDIN-4-ONE CHELATORS, EFFICACY, L1, 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE, DESFERRIOXAMINE, TOXICITY, INVIVO, OVERLOAD, CELLS, RAT
UCL classification: UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Haematology
URI: http://discovery.ucl.ac.uk/id/eprint/91644
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item